ANNEXON BIOSCIENCES
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. The company’s first product... candidate, ANX005, is a full-length monoclonal antibody formulated for intravenous administration in autoimmune and neurodegenerative disorders. The company’s second product candidate, ANX007, is a monoclonal antibody Fab formulated for intravitreal administration for the treatment of neurodegenerative ophthalmic disorders. Annexon is advancing its current programs while evaluating additional orphan and large market indications. Annexon is deploying a disciplined, biomarker-driven development strategy designed to establish that its product candidates are engaging the target at a well-tolerated therapeutic dose in the intended patient tissue.
ANNEXON BIOSCIENCES
Industry:
Biotechnology Health Care Health Diagnostics Life Science Therapeutics
Founded:
2011-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.annexonbio.com
Total Employee:
51+
Status:
Active
Contact:
(650)822-5500
Total Funding:
634 M USD
Technology used in webpage:
Domain Not Resolving Google Maps CrUX Top 50m Amazon Virginia Region CloudFront COVID-19 Amazon Route 53 Amazon SSL Symantec Secure Site
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Ambrx
Ambrx develops protein therapeutics that preserve potency, reduce dosing frequency, and improve homogeneity of the drug substance.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Kezar Life Sciences
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Salvo Health
Launching specialty health clinics to radically improve member outcomes.
Simple HealthKit
Simple HealthKit provides rapid diagnostic solutions, and wellness tests for universities, employers, clinics, and pharmacies.
Spark Neuro
SPARK Neuro is a neuroscience company that revolutionizes the of audience engagement in advertising and entertainment.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
2011-08-01
Board_member
Board_member
2018-12-01
Board_member
2022-01-01
Current Employees Featured
Jennifer Lew EVP & CFO @ Annexon Biosciences
EVP & CFO
Jamie Dananberg Chief Medical Officer @ Annexon Biosciences
Chief Medical Officer
2023-07-01
Michael Overdorf Executive Vice President and Chief Business Officer @ Annexon Biosciences
Executive Vice President and Chief Business Officer
Ted Yednock EVP & CIO @ Annexon Biosciences
EVP & CIO
2021-09-01
Larry C. Mattheakis CSO @ Annexon Biosciences
CSO
2021-09-01
Eric Humphriss Vice President, Global Clinical Operations @ Annexon Biosciences
Vice President, Global Clinical Operations
2018-10-01
Douglas Love President & Chief Executive Officer @ Annexon Biosciences
President & Chief Executive Officer
2014-12-01
Ben Barres Founder @ Annexon Biosciences
Founder
Founder
Stock Details
Investors List
Satter Investment Management
Satter Investment Management investment in Post-IPO Equity - Annexon Biosciences
Fairmount Funds Management
Fairmount Funds Management investment in Post-IPO Equity - Annexon Biosciences
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - Annexon Biosciences
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Annexon Biosciences
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Annexon Biosciences
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Annexon Biosciences
Redmile Group
Redmile Group investment in Post-IPO Equity - Annexon Biosciences
Satter Investment Management
Satter Investment Management investment in Series C - Annexon Biosciences
New Enterprise Associates
New Enterprise Associates investment in Series C - Annexon Biosciences
Adage Capital Management
Adage Capital Management investment in Series C - Annexon Biosciences
Key Employee Changes
Official Site Inspections
http://www.annexonbio.com Semrush global rank: 2.59 M Semrush visits lastest month: 7 K
- Host name: 41.102.145.34.bc.googleusercontent.com
- IP address: 34.145.102.41
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Annexon Biosciences"
About - Annexon Biosciences
OUR MISSION We’re passionate about bringing game-changing therapies to patients suffering from serious complement-mediated autoimmune, neurodegenerative and ophthalmic disorders OUR History 2007 Dr. Ben …See details»
Annexon Biosciences Expands Leadership Team with the …
“I’m pleased to welcome Michael to our organization as we look to leverage his expertise across the organization, and in particular with regard to our corporate and commercial development …See details»
News Release Details - ir.annexonbio.com
To learn more visit annexonbio.com. Forward Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as …See details»
Annexon Biosciences - Crunchbase Company Profile
Contact Email info@annexonbio.com Phone Number (650)822-5500 Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the …See details»
Annexon Biosciences - LinkedIn
Annexon Biosciences | 6,979 followers on LinkedIn. Unlocking the Next Generation of Complement Therapies | Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical …See details»
Annexon Biosciences - The Org
Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, …See details»
Annexon Biosciences Overview | SignalHire Company Profile
Organization Website. annexonbio.com . Social Links. Contact Email [email protected] Phone Number. 650-822-5500. Annexon Biosciences industries. Biotech, Medical Research & …See details»
Annexon Biosciences Company Profile: Overview and Full News …
Annexonbio.com. Overview: Annexon Biosciences. Annexon Biosciences, based in California, is a biopharmaceutical company focused on developing therapies for classical complement-driven …See details»
News Releases - Annexon Inc.
Jan 7, 2025 The Investor Relations website contains information about Annexon Inc.'s business for stockholders, potential investors, and financial analysts.See details»
News Release Details - ir.annexonbio.com
“I’m pleased to welcome Michael to our organization as we look to leverage his expertise across the organization, and in particular with regard to our corporate and commercial development …See details»
Annexon Biosciences - Craft
Oct 29, 2024 Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, …See details»
Our Culture - Annexon Biosciences
Our Culture Literally show up as you are — just show up and add value.Our culture is very open and direct, but very respectful.There’s a casual intensity to us where we seek to have fun while …See details»
Annexon Biosciences - Bain Capital Life Sciences
Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company utilizing a distinct scientific approach to stop C1q and all inflammatory aspects of classical complement …See details»
Annexon - Overview, News & Similar companies | ZoomInfo.com
Annexon contact info: Phone number: (650) 822-5500 Website: annexonbio.com What does Annexon do? Annexon is a clinical-stage biopharmaceutical company developing a pipeline of …See details»
Annexon Expands Board of Directors with Appointment of
6 days ago To learn more visit annexonbio.com. Forward Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the …See details»
News Release Details - Annexon Inc.
SOUTH SAN FRANCISCO, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Today Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a …See details»
Careers - Annexon Biosciences
The strength of the team is each individual member. The strength of each member is the team. – Phil Jackson, former Los Angeles Lakers head coach OUR Values Warrior Spirit Desire to be …See details»
Annexon Expands Board of Directors with Appointment of …
Jan 10, 2025 To learn more visit annexonbio.com. Forward Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the …See details»
Annexon Announces Proposed Public Offering of Common Stock
BRISBANE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for …See details»
Pipeline - Annexon Biosciences
STOP COMPLEMENT-MEDIATED DISEASES AT THE START Annexon is pioneering a class of new complement medicines for patients with classical complement-mediated disorders of the …See details»